Stratos Wealth Advisors LLC purchased a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 9,465 shares of the real estate investment trust’s stock, valued at approximately $216,000.
Other hedge funds also recently made changes to their positions in the company. Douglas Lane & Associates LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at $33,947,000. Presima Securities ULC bought a new position in shares of Healthpeak Properties in the third quarter valued at $22,465,000. AMF Tjanstepension AB bought a new position in shares of Healthpeak Properties in the third quarter valued at $15,548,000. Handelsbanken Fonder AB bought a new position in shares of Healthpeak Properties in the third quarter valued at $11,668,000. Finally, Brookstone Capital Management bought a new position in shares of Healthpeak Properties in the third quarter valued at $11,018,000. 93.57% of the stock is owned by institutional investors.
Healthpeak Properties Stock Up 1.1 %
DOC opened at $22.43 on Wednesday. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.14. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market capitalization of $15.79 billion, a P/E ratio of 64.09, a P/E/G ratio of 2.27 and a beta of 1.14. The stock has a fifty day moving average of $22.19 and a 200-day moving average of $20.60.
Analysts Set New Price Targets
Several research firms recently weighed in on DOC. Evercore ISI raised their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. Wedbush raised their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Wells Fargo & Company reissued an “equal weight” rating and issued a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. Royal Bank of Canada raised their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price target for the company from $20.00 to $28.00 in a report on Monday. One analyst has rated the stock with a sell rating, five have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $22.62.
View Our Latest Research Report on DOC
Healthpeak Properties Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
- Five stocks we like better than Healthpeak Properties
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- How Can Investors Benefit From After-Hours Trading
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.